Cargando…

Validation Study of the Oxford Classification for IgA Nephropathy in Korean Adults

Detalles Bibliográficos
Autor principal:	Choi, Bum Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443719/ https://www.ncbi.nlm.nih.gov/pubmed/23019391 http://dx.doi.org/10.3904/kjim.2012.27.3.275

Ejemplares similares

Validation of the Oxford Classification of IgA Nephropathy: A Single-Center Study in Korean Adults
por: Lee, Hoyoung, et al.
Publicado: (2012)

Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy
por: Hwang, Dohui, et al.
Publicado: (2021)

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
por: Le, Weibo, et al.
Publicado: (2012)

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
por: Coppo, Rosanna, et al.
Publicado: (2014)

IgA nephropathy and kidney transplantation according to the Oxford classification
por: Vasconcelos, André de Sá, et al.
Publicado: (2023)

Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors
por: Moriyama, Takahito, et al.
Publicado: (2020)

Reproducibility of Oxford Scoring in IgA Nephropathy: Is the Noise Due to an Educational Gap?
por: Herlitz, Leal C.
Publicado: (2023)

Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy
por: Xu, Lin-Lin, et al.
Publicado: (2023)

Systematic Review of the Oxford Classification of IgA Nephropathy: Reproducibility and Prognostic Value
por: Howie, Alexander J., et al.
Publicado: (2023)

Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy
por: Yu, Fang, et al.
Publicado: (2021)

The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis
por: Yang, Pingping, et al.
Publicado: (2017)

Oxford classification of IgA nephropathy and C4d deposition; correlation and its implication
por: Rath, Ashutosh, et al.
Publicado: (2015)

Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
por: Hirano, Keita, et al.
Publicado: (2015)

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy
por: Juan, Yun-Ting, et al.
Publicado: (2022)

Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy
por: Miyabe, Yoei, et al.
Publicado: (2021)

A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy
por: Itami, Shusaku, et al.
Publicado: (2021)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience
por: Nasri, Hamid, et al.
Publicado: (2013)

The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study
por: Wu, Heyan, et al.
Publicado: (2020)

IgA Nephropathy: A Tale of 3 Continents
por: Tang, Sydney Chi-Wai
Publicado: (2021)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Correlation of Oxford MEST-C Scores With Clinical Variables for IgA Nephropathy in South India
por: Gowrishankar, Swarnalata, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Significance of segmental glomerulosclerosis in IgA nephropathy: What is the evidence?
por: Mubarak, Muhammed, et al.
Publicado: (2013)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Analysis of the relationship between Oxford classification, IgM deposition and multiple indexes and the adverse prognosis of patients with primary IgA nephropathy and related risk factors
por: Hao, Yan, et al.
Publicado: (2019)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

GWAS reveal novel IgA nephropathy risk loci
por: Foo, Jia Nee, et al.
Publicado: (2015)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Prognostic value of chronicity grading on renal outcomes in patients with IgA nephropathy
por: Kang, Donghyuk, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram for IgA nephropathy
por: Liu, Jian, et al.
Publicado: (2017)

Steroids for IgA Nephropathy: A #NephJC Editorial on the TESTING trial
por: Chellappan, Anand, et al.
Publicado: (2022)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6rvsakvenhogug5hv5k2khj4so